This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
On this webpage you will find “The Bug Name Emoji Game” which is just like “ The Drug Name Emoji Game ” and meant to be a fun medical emoji puzzle game for people who deal with different types of microbial pathogens. Simply use the emoji symbols to decipher the corresponding organism name! These puzzles have been developed by Dr.
The district court determined that the patent is invalid on two separate grounds – lack of written description and lack of enablement, the company said.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Roche reported negative results Monday from a pair of clinical trials investigating an antibody treatment for people with early-stage Alzheimer’s disease — another setback for the Swiss pharma giant’s decades-long effort to develop medicines against the memory-destroying disease. The drug, called gantenerumab, slowed the rate of cognitive and functional decline compared to a placebo by 8% and 6%, respectively, — not enough to meet the primary goal of the two studies o
98
98
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Roche reported negative results Monday from a pair of clinical trials investigating an antibody treatment for people with early-stage Alzheimer’s disease — another setback for the Swiss pharma giant’s decades-long effort to develop medicines against the memory-destroying disease. The drug, called gantenerumab, slowed the rate of cognitive and functional decline compared to a placebo by 8% and 6%, respectively, — not enough to meet the primary goal of the two studies o
VillageMD and Walgreens now have more than 150 Village Medical at Walgreens locations in markets across the country – including in Arizona, Florida, Texas, Kentucky, Indiana, Massachusetts, New Hampshire, Georgia and Rhode Island, in addition to Neva
WASHINGTON — The outlook for the White House’s health and science priorities just got a whole lot brighter. With a Democratic Senate, as the Associated Press projected Saturday night, it will be much easier for President Biden to get nominees confirmed, including whomever he taps to lead the National Institutes of Health. Public health officials like National Institute of Allergy and Infectious Diseases Director Anthony Fauci will face less scrutiny, as Democrats will maintain powe
I have been a nurse practitioner (NP) in the adult cardiovascular surgical intensive care unit (CVICU) for over four years, and I often get asked how I was able to begin working there as a new NP. There are multiple paths to becoming an NP in the CVICU, but there are a few key components to achieving this final goal that can never be skipped no matter the path one should choose.
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
The Internal Medicine Board Exam can be fairly difficult for first-time test takers. In 2021, the First-Time Taker Pass Rate for the ABIM Internal Medicine Certification Exam was 88%. Here are a few tips and tricks that to aid your Internal Medicine board review to improve your chance of passing: Understand the Distribution of the Exam – Before you start studying, take a look at the Internal Medicine blueprint for the most up-to-date content specifications.
BCACP Study Materials – 100$ Discount and Free Audible Book We have updated our BCACP Study Materials for 2023 and we are offering a one-time discount of 100$ off of our 1 year all-access pass. In addition. I’m giving away a FREE Audible Book to the first 10 customers! What you need to do: I […]. The post Free BCACP Practice Quiz, 100$ Discount and Free Audible Book!
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Monday, November 14th, 2022 at 7am PST | 10am EST | 3pm GMT | 4pm CET Discover promotion mix optimization approaches to balance and future-fit your investment strategy and maximize the impact of your customer engagement. Harness the power of AI to measure, model, and benchmark channel response.
Psilocybin given as a single dose is effective in patients with treatment-resistant major depression in as little as three weeks. Using a single dose of psilocybin in conjunction with supportive therapy leads to a significant improvement in symptoms among patients with treatment-resistant major depression according to the findings of a study by an international team of researchers.
The US Food and Drug Administration (FDA) has granted approval for AstraZeneca ’s Imfinzi (durvalumab) plus Imjudo (tremelimumab) and platinum-based chemotherapy to treat Stage IV (metastatic) non-small cell lung cancer (NSCLC) in adults. The approval was based on the findings from the randomised, multicentre, open-label, international Phase III POSEIDON trial.
A systematic review suggests that the combination tixagevimab/cilgavimab is effective for immunocompromised patients with COVID-19. A systematic review by UK researchers, currently available as a preprint, concluded that the monoclonal antibody combination tixagevimab/cilgavimab is effective against adverse outcomes in COVID-19 including breakthrough infections, hospitalisation, intensive care unit (ITU) admission and both all-cause and COVID-19 specific mortality.
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content